| Stage | ALGN | % of rev | AIN | % of rev | Gap · A − B |
|---|---|---|---|---|---|
| Revenue | $1.1B | 100.00% | $350M | 100.00% | ALGN ×3.02 |
| Gross profit | $757M | 71.71% | $140M | 40.16% | ALGN +31.6pp |
| Operating income | $154M | 14.58% | $59M | 16.99% | AIN +2.4pp |
| Pre-tax income | $149M | 14.08% | $56M | 15.96% | AIN +1.9pp |
| Net income | $108M | 10.25% | $42M | 11.98% | AIN +1.7pp |
| Stage | ALGN | AIN | Gap · A − B |
|---|---|---|---|
| Revenue | $1.1B100.00% | $350M100.00% | ALGN ×3.02 |
| Gross profit | 71.71%$757M | 40.16%$140M | ALGN +31.6pp |
| Operating income | 14.58%$154M | 16.99%$59M | AIN +2.4pp |
| Pre-tax income | 14.08%$149M | 15.96%$56M | AIN +1.9pp |
| Net income |
| 10.25%$108M |
| 11.98%$42M |
| AIN +1.7pp |
None
No disclosed counterparties: ALGN.